(TheLibertyRevolution.Com)- China is under heavy scrutiny from the United States government right now. The Chinese Communist Party is accused of attempting to cover up the outbreak of the virus in November and December of last year. Part of that alleged cover-up includes attempting to conceal the real number of infections, scrubbing reports about the outbreak, and silencing whistleblowers.
On Monday, White House Trade Adviser Peter Navarro also suggested that China may have withheld data about the virus in a cunning plan to sell a vaccine to the rest of the world.
During an episode of Lou Dobbs Tonight on Fox Business, Navarro explained how the U.S. government believes China may have hidden the real data from the United States so that they could be first to develop a vaccine.
According to Navarro, China could have seen the situation as “a business proposition so that they can sell the vaccines to the world.”
“One of the reasons that they may not have let us in and given us the data on this virus early is they’re racing to get a vaccine,” he said. “And they think this is just a competitive business race.”
Navarro assured viewers that the United States is not lagging behind, despite the original data not being made available.
“But we’re going to beat them,” he said. “We’re going to beat them because of President Trump’s leadership. We’re going to beat them because HHS has already got a five-company horse race.”
Back in February, Navarro joined Dobbs to discuss the clinical trials for an antiviral drug that would protect people from the Chinese coronavirus. Navarro said that the clinical trials would be starting at the end of February, and they soon did. In early March, American volunteers took the vaccine in the Kaiser Permanente research facility located in Seattle, Washington.
Stopping Coronavirus. Peter Navarro says the U.S. vaccines to treat Coronavirus could be ready by November with clinical trials for an antiviral drug starting by the end of this month. #MAGA #AmericaFirst #Dobbs pic.twitter.com/Kfptahr2gh
— Lou Dobbs (@LouDobbs) February 15, 2020
Trials are currently ongoing, though it could be a year to 18 months before they are fully cleared as safe to use on humans.